Stockscreener 앱 받기
5.35
1.47%
-0.08
시간 외 거래:
5.77
0.42
+7.85%
전일 마감가:
$5.43
열려 있는:
$5.69
하루 거래량:
45,934
Relative Volume:
0.27
시가총액:
$51.54M
수익:
-
순이익/손실:
$-10.44M
주가수익비율:
-3.9908
EPS:
-1.3406
순현금흐름:
$-7.72M
1주 성능:
+1.52%
1개월 성능:
-20.62%
6개월 성능:
+424.51%
1년 성능:
+136.73%
1일 변동 폭
$5.35
$5.89
1주일 범위
$5.17
$5.89
52주 변동 폭
$0.72
$20.32
에데사 바이오테크 Stock (EDSA) Company Profile
명칭
Edesa Biotech Inc
전화
(905) 475-1234
주소
100 SPY COURT, MARKHAM, ON
Compare EDSA vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
5.35 | 51.06M | 0 | -10.44M | -7.72M | -1.3406 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
에데사 바이오테크 주식(EDSA)의 최신 뉴스
EDSA Stock Soars More Than 700% So Far This Year: Wall Street Eyes Further Upside In Run Up To Acute Kidney Injury Data Reveal - Stocktwits
Edesa Biotech (NASDAQ:EDSA) Posts Earnings Results, Misses Expectations By $0.16 EPS - marketbeat.com
Edesa Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Form 8K EDESA BIOTECH For: 13 August By Investing.com - Investing.com South Africa
Edesa Biotech Q3 loss widens 140% to $5.4M on rising R&D spend - scanx.trade
Edesa Biotech (EDSA) loss widens to $11.9M as R&D surges and cash tightens - Stock Titan
Edesa Reports $5.4 Million Q3 Loss as EB06 Phase 2 Site Activation Begins - Quiver Quantitative
Edesa Starts Activating First Vitiligo Trial Sites as Enrollment Nears - Stock Titan
Edesa Biotech Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView
Why Did EDSA Stock Rally More Than 70% Today? - Stocktwits
Edesa Biotech (EDSA) to Post Earnings on Monday - marketbeat.com
Edesa Biotech Inc (EDSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
EDSA Q3'26 Earnings: EPS estimate is (0.43) USD - TradingView
Edesa Biotech (NASDAQ: EDSA) CEO receives 5,324 restricted share units - Stock Titan
EDSA Q3'26 Earnings: revenue estimate is 0 USD - TradingView
Edesa Biotech Inc (EDSA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Edesa Biotech Inc (EDSA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Edesa Biotech Inc (EDSA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Edesa Biotech Inc (EDSA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Edesa Biotech Inc (EDSA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Edesa Biotech Inc (EDSA) Income Statement - TradingKey
Edesa Biotech (EDSA) Edges Lower Amid Thin Trading: Key Levels in FocusAndrews Pitchfork - dars.gov.et
Edesa Biotech Market Sentiment - Benzinga España
Edesa Biotech Inc (EDSA) Institutional Confidence - TradingKey
Edesa Biotech Inc (EDSA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
EDSA|Edesa Biotech Inc|Price:5.250|Chg%:-0.410 - TradingKey
Edesa Biotech (EDSA) Slips 7% as Stock Retests Key Support Near $5.00Anchored VWAP - dars.gov.et
TradingKey - TradingKey
Edesa Biotech Inc (EDSA) Balance Sheet - TradingKey
Edesa Biotech, Inc. Revenue Breakdown – NASDAQ:EDSA - TradingView
Edesa Biotech Inc (EDSA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
EDSA Stock Rallied Over 50% Today: What’s Ahead For The Small-Cap Biotech? - Stocktwits
Edesa Biotech (EDSA) Revenue BreakdownMain Composition - Moomoo
Edesa Biotech, Inc. SEC Filing (Jul 14, 2026) - Stock Titan
Edesa Biotech (EDSA) Declines 2.85% as Shares Approach Key Support ZoneIV Expansion Alert - po-news-eg.net
Edesa Biotech (EDSA) details $3.5M private placement and 729,241-share resale - Stock Titan
Edesa Biotech | 424B3: Prospectus - Moomoo
Edesa Biotech (EDSA) Holds Steady Near Support After Minimal GainsInstitutional Volume - dars.gov.et
Enterprise value to EBIT forward of Edesa Biotech, Inc. – NASDAQ:EDSA - TradingView
Edesa Biotech Company Profile & Introduction - Moomoo
Edesa Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Nijhawan Pardeep - Moomoo
EDSA Should I Buy - Intellectia AI
Form S-3 EDESA BIOTECH For: 2 July By Investing.com - Investing.com Nigeria
Edesa Biotech (EDSA) CEO receives 3,378-share RSU grant - Stock Titan
Edesa Biotech (NASDAQ: EDSA) registers 729,241 shares for resale - Stock Titan
EDSA: Positive Exploratory Data in Patients with AKI - Yahoo Finance
Edesa Biotech Inc. (EDSA) Q1 2026 Earnings: Wider-Than-Expected Loss Weighs on SharesShare Repurchase Impact - dars.gov.et
Brookline Capital Initiates Edesa Biotech(EDSA.US) With Buy Rating, Announces Target Price $21 - Moomoo
Brookline initiates Edesa Biotech stock with buy on pipeline By Investing.com - Investing.com Nigeria
Brookline initiates Edesa Biotech stock with buy on pipeline - Investing.com
에데사 바이오테크 (EDSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):